We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Cboe Global Markets
CBOE
$30.2B
| $10.6M | 0.02% |
113,600
-5,500
| -5% | -$481K |
|
577
FIVE9
FIVN
$2.17B
| $10.5M | 0.02% |
60,000
-40,000
| -40% | -$6.08M |
|
|
RPLA
578
DELISTED
Replay Acquisition Corp. Ordinary Shares
RPLA
| $10.4M | 0.02% |
+1,000,000
| New | +$10.2M |
|
579
JB Hunt Transport Services
JBHT
$25.1B
| $10.4M | 0.02% |
76,000
-3,400
| -4% | -$451K |
|
|
FPAC.U
580
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
| $10.3M | 0.02% |
+1,000,000
| New | +$10.2M |
|
581
Etsy
ETSY
$7.81B
| $10.3M | 0.02% |
+58,100
| New | +$8.74M |
|
582
Sutro Biopharma
STRO
$400M
| $10.3M | 0.02% |
47,500
-25,000
| -34% | -$4.14M |
|
|
JNCE
583
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $10.3M | 0.02% |
1,472,000
+1,368,624
| +1,324% | +$10.7M |
|
584
Wabtec
WAB
$49.9B
| $10.3M | 0.02% |
140,635
-62,600
| -31% | -$4.28M |
|
585
argenx
ARGX
$54.8B
| $10.3M | 0.02% |
35,000
+10,000
| +40% | +$2.75M |
|
586
Revvity
RVTY
$12.7B
| $10.3M | 0.02% |
+71,506
| New | +$9.52M |
|
587
Orchestra BioMed
OBIO
$249M
| $10.2M | 0.02% |
800,000
| – | – |
|
|
DWIN.U
588
DELISTED
Delwinds Insurance Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
DWIN.U
| $10.2M | 0.02% |
+1,000,000
| New | +$10.1M |
|
589
Huntington Bancshares
HBAN
$35.1B
| $10.2M | 0.02% |
805,793
+61,493
| +8% | +$699K |
|
590
AXIS Capital
AXS
$7.62B
| $10.1M | 0.02% |
200,000
-100,000
| -33% | -$4.85M |
|
591
DaVita
DVA
$11.5B
| $10.1M | 0.02% |
85,700
+70,400
| +460% | +$7.17M |
|
592
Lincoln National
LNC
$8.93B
| $10M | 0.02% |
199,461
+32,200
| +19% | +$1.37M |
|
|
CERE
593
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $9.95M | 0.02% |
600,000
+300,000
| +100% | +$3.9M |
|
594
NRG Energy
NRG
$25.1B
| $9.91M | 0.02% |
263,920
-10,300
| -4% | -$339K |
|
595
Pinnacle West Capital
PNW
$12.2B
| $9.87M | 0.02% |
123,483
-497,580
| -80% | -$41M |
|
|
CALA
596
DELISTED
Calithera Biosciences, Inc
CALA
| $9.82M | 0.02% |
+100,000
| New | +$8.76M |
|
|
CUTR
597
DELISTED
Cutera, Inc.
CUTR
| $9.72M | 0.02% |
403,000
+103,000
| +34% | +$2.2M |
|
598
Textron
TXT
$15.1B
| $9.65M | 0.02% |
199,761
-78,205
| -28% | -$3.29M |
|
599
Peabody Energy
BTU
$2.87B
| $9.64M | 0.02% |
4,000,000
+1,500,000
| +60% | +$2.43M |
|
600
NiSource
NI
$20.8B
| $9.61M | 0.02% |
418,762
-8,482
| -2% | -$198K |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.